These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8679836)
1. [Alterations of fibrinolysis in stroke]. Hernández Nuñez A; Romero Barbero JL; Cáceres Sansaloni A; Pérez de Oteyza C An Med Interna; 1996 Mar; 13(3):107-10. PubMed ID: 8679836 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281 [TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
4. [Role of the fibrinolytic system in the physiology of stroke]. Raya Sánchez JM; Hernández Nieto L An Med Interna; 1996 Mar; 13(3):105-6. PubMed ID: 8679835 [No Abstract] [Full Text] [Related]
5. Sex differences in the determinants of fibrinolytic activity. MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046 [TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis system in patients with bronchial asthma. Banach-Wawrzeńczyk E; Dziedziczko A; Rość D Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294 [TBL] [Abstract][Full Text] [Related]
7. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction. Mansfield MW; Catto AJ; Carter AM; Grant PJ Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
10. Human gender differences in fibrinolytic responses to exercise training and their determinants. Kulaputana O; Macko RF; Ghiu I; Phares DA; Goldberg AP; Hagberg JM Exp Physiol; 2005 Nov; 90(6):881-7. PubMed ID: 16118237 [TBL] [Abstract][Full Text] [Related]
11. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597 [TBL] [Abstract][Full Text] [Related]
12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
13. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus. Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874 [TBL] [Abstract][Full Text] [Related]
14. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan. Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789 [TBL] [Abstract][Full Text] [Related]
15. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
17. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis. Eriksson MA; Rask E; Johnson O; Carlström K; Ahrén B; Eliasson M; Boman K; Söderberg S Blood Coagul Fibrinolysis; 2008 Oct; 19(7):625-32. PubMed ID: 18832901 [TBL] [Abstract][Full Text] [Related]
18. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019 [TBL] [Abstract][Full Text] [Related]
19. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792 [TBL] [Abstract][Full Text] [Related]
20. Role of fibrinolytic markers in acute stroke. Abdullah WZ; Idris SZ; Bashkar S; Hassan R Singapore Med J; 2009 Jun; 50(6):604-9. PubMed ID: 19551314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]